Display Mode:

    Main content

    Health Information

    Premature Infant: Treating Underdeveloped Lungs

    Premature Infant: Treating Underdeveloped Lungs

    Skip to the navigation

    Topic Overview

    Particularly when an infant is born before 36 weeks' gestation , the lungs are immature, and the body has limited muscle strength and energy for breathing. So the premature infant may not get enough oxygen. This can cause serious health problems. It is common at birth for a premature infant to need oxygen therapy , a ventilator , and/or medicine. These can help the baby absorb oxygen and breathe.

    Infants whose lungs have been quickly matured with corticosteroid treatment before birth have a lot fewer problems than those who are not treated. With this treatment, the mother gets a shot of corticosteroids before she gives birth.

    Infants with underdeveloped lungs often lack surfactant. This is a substance that coats the airways and prevents them from collapsing and sticking together. When premature lungs are treated with surfactant after birth, the infant's blood oxygen levels usually improve within minutes. Surfactant treatment reduces the risk and the severity of respiratory distress syndrome (RDS) in premature infants. It also reduces the overall risk of death. footnote 1 Surfactant also helps treat RDS.

    Unlike corticosteroid treatment before birth, giving corticosteroids to a baby after birth is losing favor among experts. Current research is looking at how this medicine can be safely used to improve lung function without causing other problems. (It can cause neurological problems, gastrointestinal bleeding and damage, blood sugar problems, and high blood pressure.)

    Related Information



    1. Cunningham FG, et al. (2010). Diseases and injuries of the fetus and newborn. In Williams Obstetrics, 23rd ed., pp. 605-643. New York: McGraw-Hill.

    Other Works Consulted

    • Engle WA, Committee on Fetus and Newborn (2008). Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics, 121(2): 419-432.
    • Soll R, –zek E (2010). Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews (1).


    ByHealthwise Staff
    Primary Medical Reviewer Sarah Marshall, MD - Family Medicine
    Specialist Medical Reviewer Kimberly Dow, MD, FRCPC - Neonatology

    Current as ofSeptember 9, 2014

    Current as of: September 9, 2014

    This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

    © 1995-2015 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.